Receptor status change from primary to residual breast cancer after neoadjuvant chemotherapy and analysis of survival outcomes.
Saved in:
| Title: | Receptor status change from primary to residual breast cancer after neoadjuvant chemotherapy and analysis of survival outcomes. |
|---|---|
| Authors: | Parinyanitikul N; Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX., Lei X; Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX., Chavez-MacGregor M; Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX., Liu S; Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX., Mittendorf EA; Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX., Litton JK; Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX., Woodward W; Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX., Zhang AH; Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX., Hortobagyi GN; Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX., Valero V; Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX., Meric-Bernstam F; Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Department of Investigational Cancer Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX. Electronic address: fmeric@mdanderson.org., Gonzalez-Angulo AM; Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Department of Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. |
| Source: | Clinical breast cancer [Clin Breast Cancer] 2015 Apr; Vol. 15 (2), pp. 153-60. Date of Electronic Publication: 2014 Oct 02. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 25454687 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Receptor status change from primary to residual breast cancer after neoadjuvant chemotherapy and analysis of survival outcomes. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Parinyanitikul+N%22">Parinyanitikul N</searchLink>; Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Lei+X%22">Lei X</searchLink>; Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Chavez-MacGregor+M%22">Chavez-MacGregor M</searchLink>; Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Liu+S%22">Liu S</searchLink>; Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Mittendorf+EA%22">Mittendorf EA</searchLink>; Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Litton+JK%22">Litton JK</searchLink>; Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Woodward+W%22">Woodward W</searchLink>; Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Zhang+AH%22">Zhang AH</searchLink>; Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Hortobagyi+GN%22">Hortobagyi GN</searchLink>; Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Valero+V%22">Valero V</searchLink>; Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Meric-Bernstam+F%22">Meric-Bernstam F</searchLink>; Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Department of Investigational Cancer Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX. Electronic address: fmeric@mdanderson.org.<br /><searchLink fieldCode="AU" term="%22Gonzalez-Angulo+AM%22">Gonzalez-Angulo AM</searchLink>; Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Department of Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100898731%22">Clinical breast cancer</searchLink> [Clin Breast Cancer] 2015 Apr; Vol. 15 (2), pp. 153-60. <i>Date of Electronic Publication: </i>2014 Oct 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100898731 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1938-0666 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215268209%22">15268209 </searchLink><i>NLM ISO Abbreviation: </i>Clin Breast Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=25454687 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.clbc.2014.09.006 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 153 Titles: – TitleFull: Receptor status change from primary to residual breast cancer after neoadjuvant chemotherapy and analysis of survival outcomes. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Parinyanitikul N – PersonEntity: Name: NameFull: Lei X – PersonEntity: Name: NameFull: Chavez-MacGregor M – PersonEntity: Name: NameFull: Liu S – PersonEntity: Name: NameFull: Mittendorf EA – PersonEntity: Name: NameFull: Litton JK – PersonEntity: Name: NameFull: Woodward W – PersonEntity: Name: NameFull: Zhang AH – PersonEntity: Name: NameFull: Hortobagyi GN – PersonEntity: Name: NameFull: Valero V – PersonEntity: Name: NameFull: Meric-Bernstam F – PersonEntity: Name: NameFull: Gonzalez-Angulo AM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2015 Apr Type: published Y: 2015 Identifiers: – Type: issn-electronic Value: 1938-0666 Numbering: – Type: volume Value: 15 – Type: issue Value: 2 Titles: – TitleFull: Clinical breast cancer Type: main |
| ResultId | 1 |